Selected research
Market Structure
Global Metformin HCl API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Metformin HCl API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Metformin HCl API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Metformin HCl API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metformin HCl API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Metformin HCl API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metformin HCl API include Shijiazhuang Polee Pharmaceutical, Shouguang Fukang Pharmaceutical, CR Double-Crane, Vistin Pharma, IOLCP, Harman Finochem, Farmhispania, Exemed Pharmaceuticals and Bhupinder Singh Manhas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Metformin HCl API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Metformin HCl API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Metformin HCl API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin HCl API market size, projected growth trends, production technologies, key applications, and end-use industries.
Metformin HCl API Segment by Company
Shijiazhuang Polee Pharmaceutical
Shouguang Fukang Pharmaceutical
CR Double-Crane
Vistin Pharma
IOLCP
Harman Finochem
Farmhispania
Exemed Pharmaceuticals
Bhupinder Singh Manhas
Auro Laboratories Limited
Atom Pharma
Anant Pharmaceuticals Pvt. Ltd.
Abhilasha Pharma Pvt. Ltd.
Aarti Drugs
Metformin HCl API Segment by Type
0.995
0.99
0.97
Others
Metformin HCl API Segment by Application
Pharmaceutical Companies
Contract Research Organizations
Others
Metformin HCl API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin HCl API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin HCl API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin HCl API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Metformin HCl API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metformin HCl API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metformin HCl API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Metformin HCl API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.995
- 0.99
- 0.97
- Others
Applications
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Companies covered
- Shijiazhuang Polee Pharmaceutical
- Shouguang Fukang Pharmaceutical
- CR Double-Crane
- Vistin Pharma
- IOLCP
- Harman Finochem
- Farmhispania
- Exemed Pharmaceuticals
- Bhupinder Singh Manhas
- Auro Laboratories Limited
- Atom Pharma
- Anant Pharmaceuticals Pvt. Ltd.
- Abhilasha Pharma Pvt. Ltd.
- Aarti Drugs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Metformin HCl API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Metformin HCl API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Metformin HCl API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Metformin HCl API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Metformin HCl API Market Dynamics
- 2.1 Metformin HCl API Industry Trends
- 2.2 Metformin HCl API Industry Drivers
- 2.3 Metformin HCl API Industry Opportunities and Challenges
- 2.4 Metformin HCl API Industry Restraints
3 Metformin HCl API Market by Manufacturers
- 3.1 Global Metformin HCl API Revenue by Manufacturers (2021-2026)
- 3.2 Global Metformin HCl API Sales by Manufacturers (2021-2026)
- 3.3 Global Metformin HCl API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Metformin HCl API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin HCl API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Metformin HCl API Manufacturers, Product Type & Application
- 3.7 Global Metformin HCl API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metformin HCl API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metformin HCl API Players Market Share by Revenue in 2025
- 3.8.3 2025 Metformin HCl API Tier 1, Tier 2, and Tier 3
4 Metformin HCl API Market by Type
- 4.1 Metformin HCl API Type Introduction
- 4.1.1 0.995
- 4.1.2 0.99
- 4.1.3 0.97
- 4.1.4 Others
- 4.2 Global Metformin HCl API Sales by Type
- 4.2.1 Global Metformin HCl API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Metformin HCl API Sales by Type (2021-2032)
- 4.2.3 Global Metformin HCl API Sales Market Share by Type (2021-2032)
- 4.3 Global Metformin HCl API Revenue by Type
- 4.3.1 Global Metformin HCl API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Metformin HCl API Revenue by Type (2021-2032)
- 4.3.3 Global Metformin HCl API Revenue Market Share by Type (2021-2032)
5 Metformin HCl API Market by Application
- 5.1 Metformin HCl API Application Introduction
- 5.1.1 Pharmaceutical Companies
- 5.1.2 Contract Research Organizations
- 5.1.3 Others
- 5.2 Global Metformin HCl API Sales by Application
- 5.2.1 Global Metformin HCl API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Metformin HCl API Sales by Application (2021-2032)
- 5.2.3 Global Metformin HCl API Sales Market Share by Application (2021-2032)
- 5.3 Global Metformin HCl API Revenue by Application
- 5.3.1 Global Metformin HCl API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Metformin HCl API Revenue by Application (2021-2032)
- 5.3.3 Global Metformin HCl API Revenue Market Share by Application (2021-2032)
6 Global Metformin HCl API Sales by Region
- 6.1 Global Metformin HCl API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Metformin HCl API Sales by Region (2021-2032)
- 6.2.1 Global Metformin HCl API Sales by Region (2021-2026)
- 6.2.2 Global Metformin HCl API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Metformin HCl API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Metformin HCl API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Metformin HCl API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Metformin HCl API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Metformin HCl API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Metformin HCl API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Metformin HCl API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Metformin HCl API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Metformin HCl API Revenue by Region
- 7.1 Global Metformin HCl API Revenue by Region
- 7.1.1 Global Metformin HCl API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Metformin HCl API Revenue by Region (2021-2026)
- 7.1.3 Global Metformin HCl API Revenue by Region (2027-2032)
- 7.1.4 Global Metformin HCl API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Metformin HCl API Revenue (2021-2032)
- 7.2.2 North America Metformin HCl API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Metformin HCl API Revenue (2021-2032)
- 7.3.2 Europe Metformin HCl API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Metformin HCl API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Metformin HCl API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Metformin HCl API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Metformin HCl API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shijiazhuang Polee Pharmaceutical
- 8.1.1 Shijiazhuang Polee Pharmaceutical Company Information
- 8.1.2 Shijiazhuang Polee Pharmaceutical Business Overview
- 8.1.3 Shijiazhuang Polee Pharmaceutical Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shijiazhuang Polee Pharmaceutical Metformin HCl API Product Portfolio
- 8.1.5 Shijiazhuang Polee Pharmaceutical Recent Developments
- 8.2 Shouguang Fukang Pharmaceutical
- 8.2.1 Shouguang Fukang Pharmaceutical Company Information
- 8.2.2 Shouguang Fukang Pharmaceutical Business Overview
- 8.2.3 Shouguang Fukang Pharmaceutical Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shouguang Fukang Pharmaceutical Metformin HCl API Product Portfolio
- 8.2.5 Shouguang Fukang Pharmaceutical Recent Developments
- 8.3 CR Double-Crane
- 8.3.1 CR Double-Crane Company Information
- 8.3.2 CR Double-Crane Business Overview
- 8.3.3 CR Double-Crane Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CR Double-Crane Metformin HCl API Product Portfolio
- 8.3.5 CR Double-Crane Recent Developments
- 8.4 Vistin Pharma
- 8.4.1 Vistin Pharma Company Information
- 8.4.2 Vistin Pharma Business Overview
- 8.4.3 Vistin Pharma Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Vistin Pharma Metformin HCl API Product Portfolio
- 8.4.5 Vistin Pharma Recent Developments
- 8.5 IOLCP
- 8.5.1 IOLCP Company Information
- 8.5.2 IOLCP Business Overview
- 8.5.3 IOLCP Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 IOLCP Metformin HCl API Product Portfolio
- 8.5.5 IOLCP Recent Developments
- 8.6 Harman Finochem
- 8.6.1 Harman Finochem Company Information
- 8.6.2 Harman Finochem Business Overview
- 8.6.3 Harman Finochem Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Harman Finochem Metformin HCl API Product Portfolio
- 8.6.5 Harman Finochem Recent Developments
- 8.7 Farmhispania
- 8.7.1 Farmhispania Company Information
- 8.7.2 Farmhispania Business Overview
- 8.7.3 Farmhispania Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Farmhispania Metformin HCl API Product Portfolio
- 8.7.5 Farmhispania Recent Developments
- 8.8 Exemed Pharmaceuticals
- 8.8.1 Exemed Pharmaceuticals Company Information
- 8.8.2 Exemed Pharmaceuticals Business Overview
- 8.8.3 Exemed Pharmaceuticals Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Exemed Pharmaceuticals Metformin HCl API Product Portfolio
- 8.8.5 Exemed Pharmaceuticals Recent Developments
- 8.9 Bhupinder Singh Manhas
- 8.9.1 Bhupinder Singh Manhas Company Information
- 8.9.2 Bhupinder Singh Manhas Business Overview
- 8.9.3 Bhupinder Singh Manhas Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bhupinder Singh Manhas Metformin HCl API Product Portfolio
- 8.9.5 Bhupinder Singh Manhas Recent Developments
- 8.10 Auro Laboratories Limited
- 8.10.1 Auro Laboratories Limited Company Information
- 8.10.2 Auro Laboratories Limited Business Overview
- 8.10.3 Auro Laboratories Limited Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Auro Laboratories Limited Metformin HCl API Product Portfolio
- 8.10.5 Auro Laboratories Limited Recent Developments
- 8.11 Atom Pharma
- 8.11.1 Atom Pharma Company Information
- 8.11.2 Atom Pharma Business Overview
- 8.11.3 Atom Pharma Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Atom Pharma Metformin HCl API Product Portfolio
- 8.11.5 Atom Pharma Recent Developments
- 8.12 Anant Pharmaceuticals Pvt. Ltd.
- 8.12.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
- 8.12.2 Anant Pharmaceuticals Pvt. Ltd. Business Overview
- 8.12.3 Anant Pharmaceuticals Pvt. Ltd. Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Anant Pharmaceuticals Pvt. Ltd. Metformin HCl API Product Portfolio
- 8.12.5 Anant Pharmaceuticals Pvt. Ltd. Recent Developments
- 8.13 Abhilasha Pharma Pvt. Ltd.
- 8.13.1 Abhilasha Pharma Pvt. Ltd. Company Information
- 8.13.2 Abhilasha Pharma Pvt. Ltd. Business Overview
- 8.13.3 Abhilasha Pharma Pvt. Ltd. Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Abhilasha Pharma Pvt. Ltd. Metformin HCl API Product Portfolio
- 8.13.5 Abhilasha Pharma Pvt. Ltd. Recent Developments
- 8.14 Aarti Drugs
- 8.14.1 Aarti Drugs Company Information
- 8.14.2 Aarti Drugs Business Overview
- 8.14.3 Aarti Drugs Metformin HCl API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Aarti Drugs Metformin HCl API Product Portfolio
- 8.14.5 Aarti Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Metformin HCl API Value Chain Analysis
- 9.1.1 Metformin HCl API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Metformin HCl API Production Mode & Process
- 9.2 Metformin HCl API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metformin HCl API Distributors
- 9.2.3 Metformin HCl API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst